Pfizer (PFE) Tops Q1 EPS by 15c, Guidance Misses Consensus
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $25.21 -2.74%
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $1.62, $0.15 better than the analyst estimate of $1.47. Revenue for the quarter came in at $25.7 billion versus the consensus estimate of $23.86 billion.
GUIDANCE:
Pfizer sees FY2022 EPS of $6.25-$6.45, versus the consensus of $7.15. Pfizer sees FY2022 revenue of $98-102 billion, versus the consensus of $107.9 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer reaffirms 2026 guidance after CFO transition news
- Pfizer Announces Chief Financial Officer Transition
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
